
Tower Health COVID-19 Vaccine Update for Community
WEST READING, PA — Even as distribution of the COVID-19 vaccine accelerates within our community, members of the public may have questions about how distribution works and why it can …
Read MoreChester County News and Community Website
WEST READING, PA — Even as distribution of the COVID-19 vaccine accelerates within our community, members of the public may have questions about how distribution works and why it can …
Read MoreHARRISBURG, PA — The Pennsylvania Department of Health confirmed Pennsylvania hospitals began receiving shipments of the Pfizer-BioNTech COVID-19 vaccine the week of Dec. 14 and Moderna COVID-19 vaccine the week …
Read MoreWEST READING, PA — Tower Health states it is following Centers for Disease Control (CDC) and PA Department of Health (DOH) guidelines for prioritizing distribution of the COVID-19 vaccine. Until …
Read MoreHARRISBURG, PA — Secretary of Health Dr. Rachel Levine recently announced the federal Pharmacy Partnership for Long-Term Care Program has begun vaccinating residents and staff at 126 Pennsylvania skilled nursing facilities using the …
Read MoreWASHINGTON, D.C. — The U.S. Department of the Health and Human Services (HHS) and the Department of Defense (DOD) jointly announced an agreement with Merck to support advanced development and …
Read MoreWAHINGTON, D.C. — The Trump Administration, through the U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD), will purchase an additional 100 million doses of COVID-19 …
Read MoreHARRISBURG, PA — The Wolf Administration announced as of December 21, 22 additional hospitals have received 30,255 doses of the Pfizer-BioNTech COVID-19 vaccine and will begin distributing it to health …
Read MoreHARRISBURG, PA — The Department of Health and Human Services (HHS) this week announced that the Centers for Disease Control and Prevention (CDC) will award $140 million for COVID-19 vaccine …
Read MoreWASHINGTON, D.C. — The U.S. Department of Health and Human Services recently announced plans to allocate initial doses of Regeneron’s investigational monoclonal antibody therapeutic, casirivimab and imdevimab, which received emergency …
Read MoreWASHINGTON, D.C. — The U.S. Department of Health and Human Services this week announced plans to allocate initial doses of Eli Lilly and Company’s investigational monoclonal antibody therapeutic, bamlanivimab, which …
Read More